In re Cyclobenzaprine Hydrochloride Extended- Release Capsule Patent Litig.
676 F.3d 1063102 USPQ2d 1760Fed. Cir.
AI-generated holding
Despite prima facie and rebuttal terminology, a fact finder must consider all evidence of obviousness and nonobviousness, including objective indicia, before reaching an obviousness determination.
Generated summary for orientation only — not legal advice. Verify against the opinion.